In most of the world, disease burden is shifting toward non-communicable diseases and injuries and is less driven by infectious illnesses. Over the past 20 years, HIV has become a manageable chronic illness for people who can be tested and treated. Interventions such as antiretroviral therapies (ART), prophylaxis, and prevention of mother-to-child transmission have been successful. The burden of HIV/AIDS has increased in Southern sub-Saharan Africa, however, where access to medical care may be limited. And although the epidemic peaked in magnitude in 2005, more than 35 million people are living with HIV worldwide.
Billions of dollars are spent every year to fight HIV/AIDS in low-income countries. IHME tracks mortality and disease burden from HIV/AIDS through the Global Burden of Disease (GBD) study, and funding for interventions in low-resource settings through our Financing Global Health work.